US EditionPublished • loading... • Updated
Dual GIP/GLP-1 Drug Linked to Reduced Diabetic Retinopathy Incidence
Summary by MedPage Today
2 Articles
2 Articles
MedPage TodayReposted by 
Anti-Aging, Acupuncture and Health News
Anti-Aging, Acupuncture and Health NewsDual GIP/GLP-1 Drug Linked to Reduced Diabetic Retinopathy Incidence
(MedPage Today) -- Use of tirzepatide (Mounjaro, Zepbound) was tied to a reduced incidence of new or progressive diabetic retinopathy and fewer complications in patients with diabetes and overweight/obesity, a retrospective study suggested. In...
·New York, United States
Read Full ArticleCoverage Details
Total News Sources2
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
